Country: Իռլանդիա
language: անգլերեն
source: HPRA (Health Products Regulatory Authority)
VERAPAMIL HYDROCHLORIDE
LTT Pharma Limited
VERAPAMIL HYDROCHLORIDE
240 Milligram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
ISOPTIN SR 240MG PROLONGED-RELEASE TABLETS (verapamil hydrochloride) PATIENT INFORMATION LEAFLET IMPORTANT INFORMATION * Read all of this leaflet carefully before you start taking this medicine * Keep this leaflet as you may need to read it again * This leaflet provides a summary of the information currently available about Isoptin SR * For further information or advice ask your doctor or pharmacist * This medicine is for you only and should never be given to anyone else, even if they appear to have the same symptoms as you * Tell your doctor or pharmacist if you experience any side effects Leaflet contents: What is Isoptin SR and what it is used for? What you need to know before you take Isoptin SR How should you take your tablets? Possible side effects. How should you store your tablets? Further information. WHAT IS ISOPTIN SR AND WHAT IT IS USED FOR? Isoptin SR tablets belong to a group of medicines called calcium channel blockers. Calcium channel blockers change the amount of calcium getting into the muscle cells in your heart and blood vessels. This can change the strength and speed with which your heart beats. It also opens up the blood vessels so blood can be pumped around the body more easily. This helps more oxygen to get to your heart muscle and can lower your blood pressure. Isoptin SR tablets are used to treat hypertension (high blood pressure) and to prevent angina (chest pain) attacks. The active ingredient in Isoptin SR tablets is verapamil hydrochloride. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ISOPTIN SR DO NOT TAKE ISOPTIN SR IF: * you are sensitive (allergic) to verapamil or any of the ingredients in the tablets? (See Section 6) * your blood pressure is extremely low as a result of heart problems (such as during shock) * you have recently had a severe heart attack * you have heart failure or second or third degree heart block (impaired nerve signal in the heart – causing a very slow heartbeat) or an electrical abnormality of the heart (atrial fibrillation/flut read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Isoptin SR 240mg Prolonged-Release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Isoptin SR 240mg Prolonged-Release Tablet contains 240 mg verapamil hydrochloride. Excipients: Each prolonged release tablet contains up to 32mg (1.39 mmol) sodium. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release tablet. _Product imported from Poland._ Isoptin SR tablets are light green, oblong in shape and marked with two triangles on one side. The tablets can be divided into equal halves but must not be crushed or chewed. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Isoptin SR 240 mg Prolonged Release Tablets are indicated in the treatment of mild to moderate hypertension and coronary heart disease, i.e. prophylaxis of myocardial ischaemia, angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. _Hypertension: _The adult dose is one tablet (240 mg) in the morning, increasing if necessary after one week to 240 mg in the morning and 240 mg in the evening, with an interval of 12 hours. In elderly patients, the initial dose is half a tablet (120 mg) in the morning, increasing by 120 mg increments at weekly intervals according to patient response. _Angina pectoris: _The usual dose is 120-240 mg twice daily according to patient response. It is recommended that low initial doses with upward titration are used in new patients. Verapamil should not be taken with grapefruit juice (see interactions). In patients with impaired liver function, metabolism of the drug is delayed to a greater or lesser extent depending on the severity of hepatic dysfunction, thus potentiating and prolonging the effects of verapamil hydrochloride. Therefore, the dosage nee read_full_document